Symposium on Health Law and Intellectual Property @ De Paul College of Law [Feb 22, Chicago, IL]: Register by Feb 19

DePaul University’s Mary and Michael Jaharis Health Law Institute and the Center for Intellectual Property Law and Information Technology (CIPLIT®) are organizing a one-day conference on pandemic diseases.

The conference will focus on “best practices” in responding to emerging pandemic diseases, including:

(1) how public health systems around the globe and in the United States can detect and should respond to threats of pandemic disease;

(2) how to develop technologies to diagnose and treat pandemic diseases;

(3) how to protect against pandemic disease agents as weapons and what civil liberties may be affected in a pandemic disease outbreak; and

(4) what rights people infected with pandemic diseases may have in regard to their privacy and treatment, as well as for any bodily property that may become involved in disease responses.

The conference will include panels of academics and practitioners addressing the specific issues, and will feature talks by two distinguished keynote speakers, who have been deeply involved in pandemic disease responses and initiatives: Lawrence Gostin–University Professor and Faculty Director, O’Neill Institute for National and Global Health Law, Georgetown University–and Richard Wilder–Associate General Counsel, Global Health Program, Bill and Melinda Gates Foundation.

Transcripts of the panels and talks will be available on-line after the conference, and papers from the conference will be published in the DePaul Journal of Health Care Law, the DePaul Journal of Art, Technology & Intellectual Property Law (JATIP), and the DePaul Law Review, which are co-sponsoring the conference.

Registration

Register online at this link.

Location

DePaul Center, 1 E Jackson Boulevard
Room 8005, Chicago, IL 60604
United States

Contact

De Paul College of Law
Loop Campus, 25 E. Jackson Blvd.
Chicago, IL 60604
(312) 362-8701

For details, view the official link given here

 

0 Shares

Comment via Facebook

Add a Comment

Your email address will not be published. Required fields are marked *